title: Administration of glucocorticoids in boys with Duchenne muscular dystrophy.
abstract: Duchenne muscular dystrophy (DMD) is the most common neuromuscular disease affecting boys. Advances in their care can delay the progression of DMD-related disability and prolong survival. The administration of glucocorticoids is among these advances. Glucocorticoid therapy, however, is associated with a myriad of potential adverse effects, and treating physicians as well as patients and their family members must understand the benefit/risk ratio of glucocorticoid therapy. Although current best evidence supports the use of glucocorticoids in patients with DMD, many are not offered the option. Considerable variability in practice also exists regarding when and how these drugs should be administered.
authors.forename: Amparo
authors.initials: A
authors.lastname: Gutierrez
authors.forename: John D
authors.initials: JD
authors.lastname: England
mesh_terms: D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D055815:Young Adult
chemical_list: D005938:Glucocorticoids